CLIN RES HEPATOL GAS 润色咨询

Clinics and Research in Hepatology and Gastroenterology

出版年份:2011 年文章数:1022 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:1.4% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1237970, encodeId=f02f123e970fc, content=偏重的研究方向:肝病;肝癌<br>经验分享:开始新的征程,实时分享投稿经历🤡别问我为啥是新征程,因为才被拒稿过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Thu Aug 11 00:51:40 CST 2022, time=2022-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170370, encodeId=4a2a21e037007, content=请问大家同行评审专家都是多久接受邀请啊,我的编辑发了15个邀请 四天啦一个都没接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8a09064593, createdName=ms4000001526222582, createdTime=Wed Nov 22 23:41:33 CST 2023, time=2023-11-22, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=949171, encodeId=c7e99491e1ca, content=我投出去两个半月了,一直在under review ,期待能快一点点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a421634926, createdName=1dd90bdfm89(暂无匿称), createdTime=Thu Mar 18 09:42:08 CST 2021, time=2021-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800183, encodeId=264180018340, content=投稿4天,还是submited to journal. 请问多久可以送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJezw9rLVo7scpm4bIb34WhXb0deaXB8picW5eMAazAJHqyt2iaj4Zw6Uecu7jrAcuWiax5TTGr2reoA/132, createdBy=02e72292772, createdName=Godmin, createdTime=Mon Jun 29 06:54:57 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=910195, encodeId=711291019566, content=请问大概多久分配稿号?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/09/04/700865284ff0a20865522250bbdae373.jpg, createdBy=1d172433504, createdName=vdujun, createdTime=Tue Dec 22 20:57:53 CST 2020, time=2020-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2182576, encodeId=f7b821825e68a, content=请问大家返修都给了多少时间呀?谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=845f5720458, createdName=ms5000000716025452, createdTime=Fri Jan 19 10:02:26 CST 2024, time=2024-01-19, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=807192, encodeId=572a80e192cf, content=两个月了,还在under review. 这么慢的嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=94665282539, createdName=14847382m81(暂无昵称), createdTime=Mon Aug 10 08:45:39 CST 2020, time=2020-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2187185, encodeId=9fd0218e1851a, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:消化病;胃肠道<br>经验分享:第一篇sci,新年最好的礼物,<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'><a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a></a>感谢杂志!编辑和审稿人很认真,从提交到录用共3个月不到,不着急的话推荐投稿! 23.11.15提交 23.11.22under review 15个邀请0接受 24.12.07 under review 21个邀请1接受 24.12.27 under review1个审完 24.1.15 under review22邀请 2个审完 RRC 24.1.15 revise 没有显示大修还是小修,两位审稿人很友好,意见态度也很积极,共不到十条修改意见。 24.1.17 修回 24.1.21 编辑收到,没有送外审,直接给了暂时接受!但提了两条意见。很激动当天修回。 24.2.11 accept 本以为最多两天,苦苦等了半个多月,很煎熬,还好最终大年初二接受了。<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'><a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a></a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/cb0fe5ba5559418e8d524afe6a4ae9c4.jpeg, type=image, width=782, height=306)], authenticateStatus=null, createdAvatar=null, createdBy=b8a09064593, createdName=ms4000001526222582, createdTime=Tue Feb 13 20:21:48 CST 2024, time=2024-02-13, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2149146, encodeId=55f92149146fb, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:肝癌<br>经验分享:中了,很速度,审稿人也很认真,谢谢这篇杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80458221003, createdName=ms5000000357159433, createdTime=Fri Jul 21 14:01:28 CST 2023, time=2023-07-21, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2175408, encodeId=3b7b21e54082a, content=投稿命中率:5.0<br>偏重的研究方向:胃肠道;肝癌<br>经验分享:审稿人也太慢了卧槽, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76045326057, createdName=148bbd99m80暂无昵称, createdTime=Sun Dec 17 10:56:23 CST 2023, time=2023-12-17, status=1, ipAttribution=浙江省)]
    2022-08-11 Doctor小雷

    偏重的研究方向:肝病;肝癌
    经验分享:开始新的征程,实时分享投稿经历🤡别问我为啥是新征程,因为才被拒稿过

    15

    展开15条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=1237970, encodeId=f02f123e970fc, content=偏重的研究方向:肝病;肝癌<br>经验分享:开始新的征程,实时分享投稿经历🤡别问我为啥是新征程,因为才被拒稿过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Thu Aug 11 00:51:40 CST 2022, time=2022-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170370, encodeId=4a2a21e037007, content=请问大家同行评审专家都是多久接受邀请啊,我的编辑发了15个邀请 四天啦一个都没接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8a09064593, createdName=ms4000001526222582, createdTime=Wed Nov 22 23:41:33 CST 2023, time=2023-11-22, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=949171, encodeId=c7e99491e1ca, content=我投出去两个半月了,一直在under review ,期待能快一点点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a421634926, createdName=1dd90bdfm89(暂无匿称), createdTime=Thu Mar 18 09:42:08 CST 2021, time=2021-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800183, encodeId=264180018340, content=投稿4天,还是submited to journal. 请问多久可以送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJezw9rLVo7scpm4bIb34WhXb0deaXB8picW5eMAazAJHqyt2iaj4Zw6Uecu7jrAcuWiax5TTGr2reoA/132, createdBy=02e72292772, createdName=Godmin, createdTime=Mon Jun 29 06:54:57 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=910195, encodeId=711291019566, content=请问大概多久分配稿号?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/09/04/700865284ff0a20865522250bbdae373.jpg, createdBy=1d172433504, createdName=vdujun, createdTime=Tue Dec 22 20:57:53 CST 2020, time=2020-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2182576, encodeId=f7b821825e68a, content=请问大家返修都给了多少时间呀?谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=845f5720458, createdName=ms5000000716025452, createdTime=Fri Jan 19 10:02:26 CST 2024, time=2024-01-19, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=807192, encodeId=572a80e192cf, content=两个月了,还在under review. 这么慢的嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=94665282539, createdName=14847382m81(暂无昵称), createdTime=Mon Aug 10 08:45:39 CST 2020, time=2020-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2187185, encodeId=9fd0218e1851a, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:消化病;胃肠道<br>经验分享:第一篇sci,新年最好的礼物,<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'><a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a></a>感谢杂志!编辑和审稿人很认真,从提交到录用共3个月不到,不着急的话推荐投稿! 23.11.15提交 23.11.22under review 15个邀请0接受 24.12.07 under review 21个邀请1接受 24.12.27 under review1个审完 24.1.15 under review22邀请 2个审完 RRC 24.1.15 revise 没有显示大修还是小修,两位审稿人很友好,意见态度也很积极,共不到十条修改意见。 24.1.17 修回 24.1.21 编辑收到,没有送外审,直接给了暂时接受!但提了两条意见。很激动当天修回。 24.2.11 accept 本以为最多两天,苦苦等了半个多月,很煎熬,还好最终大年初二接受了。<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'><a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a></a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/cb0fe5ba5559418e8d524afe6a4ae9c4.jpeg, type=image, width=782, height=306)], authenticateStatus=null, createdAvatar=null, createdBy=b8a09064593, createdName=ms4000001526222582, createdTime=Tue Feb 13 20:21:48 CST 2024, time=2024-02-13, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2149146, encodeId=55f92149146fb, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:肝癌<br>经验分享:中了,很速度,审稿人也很认真,谢谢这篇杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80458221003, createdName=ms5000000357159433, createdTime=Fri Jul 21 14:01:28 CST 2023, time=2023-07-21, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2175408, encodeId=3b7b21e54082a, content=投稿命中率:5.0<br>偏重的研究方向:胃肠道;肝癌<br>经验分享:审稿人也太慢了卧槽, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76045326057, createdName=148bbd99m80暂无昵称, createdTime=Sun Dec 17 10:56:23 CST 2023, time=2023-12-17, status=1, ipAttribution=浙江省)]
    2023-11-22 ms4000001526222582 来自青海省

    请问大家同行评审专家都是多久接受邀请啊,我的编辑发了15个邀请 四天啦一个都没接受

    5

    展开5条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=1237970, encodeId=f02f123e970fc, content=偏重的研究方向:肝病;肝癌<br>经验分享:开始新的征程,实时分享投稿经历🤡别问我为啥是新征程,因为才被拒稿过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Thu Aug 11 00:51:40 CST 2022, time=2022-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170370, encodeId=4a2a21e037007, content=请问大家同行评审专家都是多久接受邀请啊,我的编辑发了15个邀请 四天啦一个都没接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8a09064593, createdName=ms4000001526222582, createdTime=Wed Nov 22 23:41:33 CST 2023, time=2023-11-22, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=949171, encodeId=c7e99491e1ca, content=我投出去两个半月了,一直在under review ,期待能快一点点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a421634926, createdName=1dd90bdfm89(暂无匿称), createdTime=Thu Mar 18 09:42:08 CST 2021, time=2021-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800183, encodeId=264180018340, content=投稿4天,还是submited to journal. 请问多久可以送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJezw9rLVo7scpm4bIb34WhXb0deaXB8picW5eMAazAJHqyt2iaj4Zw6Uecu7jrAcuWiax5TTGr2reoA/132, createdBy=02e72292772, createdName=Godmin, createdTime=Mon Jun 29 06:54:57 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=910195, encodeId=711291019566, content=请问大概多久分配稿号?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/09/04/700865284ff0a20865522250bbdae373.jpg, createdBy=1d172433504, createdName=vdujun, createdTime=Tue Dec 22 20:57:53 CST 2020, time=2020-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2182576, encodeId=f7b821825e68a, content=请问大家返修都给了多少时间呀?谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=845f5720458, createdName=ms5000000716025452, createdTime=Fri Jan 19 10:02:26 CST 2024, time=2024-01-19, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=807192, encodeId=572a80e192cf, content=两个月了,还在under review. 这么慢的嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=94665282539, createdName=14847382m81(暂无昵称), createdTime=Mon Aug 10 08:45:39 CST 2020, time=2020-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2187185, encodeId=9fd0218e1851a, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:消化病;胃肠道<br>经验分享:第一篇sci,新年最好的礼物,<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'><a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a></a>感谢杂志!编辑和审稿人很认真,从提交到录用共3个月不到,不着急的话推荐投稿! 23.11.15提交 23.11.22under review 15个邀请0接受 24.12.07 under review 21个邀请1接受 24.12.27 under review1个审完 24.1.15 under review22邀请 2个审完 RRC 24.1.15 revise 没有显示大修还是小修,两位审稿人很友好,意见态度也很积极,共不到十条修改意见。 24.1.17 修回 24.1.21 编辑收到,没有送外审,直接给了暂时接受!但提了两条意见。很激动当天修回。 24.2.11 accept 本以为最多两天,苦苦等了半个多月,很煎熬,还好最终大年初二接受了。<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'><a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a></a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/cb0fe5ba5559418e8d524afe6a4ae9c4.jpeg, type=image, width=782, height=306)], authenticateStatus=null, createdAvatar=null, createdBy=b8a09064593, createdName=ms4000001526222582, createdTime=Tue Feb 13 20:21:48 CST 2024, time=2024-02-13, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2149146, encodeId=55f92149146fb, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:肝癌<br>经验分享:中了,很速度,审稿人也很认真,谢谢这篇杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80458221003, createdName=ms5000000357159433, createdTime=Fri Jul 21 14:01:28 CST 2023, time=2023-07-21, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2175408, encodeId=3b7b21e54082a, content=投稿命中率:5.0<br>偏重的研究方向:胃肠道;肝癌<br>经验分享:审稿人也太慢了卧槽, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76045326057, createdName=148bbd99m80暂无昵称, createdTime=Sun Dec 17 10:56:23 CST 2023, time=2023-12-17, status=1, ipAttribution=浙江省)]
    2021-03-18 1dd90bdfm89(暂无匿称)

    我投出去两个半月了,一直在under review ,期待能快一点点

    5

    展开5条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=1237970, encodeId=f02f123e970fc, content=偏重的研究方向:肝病;肝癌<br>经验分享:开始新的征程,实时分享投稿经历🤡别问我为啥是新征程,因为才被拒稿过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Thu Aug 11 00:51:40 CST 2022, time=2022-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170370, encodeId=4a2a21e037007, content=请问大家同行评审专家都是多久接受邀请啊,我的编辑发了15个邀请 四天啦一个都没接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8a09064593, createdName=ms4000001526222582, createdTime=Wed Nov 22 23:41:33 CST 2023, time=2023-11-22, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=949171, encodeId=c7e99491e1ca, content=我投出去两个半月了,一直在under review ,期待能快一点点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a421634926, createdName=1dd90bdfm89(暂无匿称), createdTime=Thu Mar 18 09:42:08 CST 2021, time=2021-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800183, encodeId=264180018340, content=投稿4天,还是submited to journal. 请问多久可以送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJezw9rLVo7scpm4bIb34WhXb0deaXB8picW5eMAazAJHqyt2iaj4Zw6Uecu7jrAcuWiax5TTGr2reoA/132, createdBy=02e72292772, createdName=Godmin, createdTime=Mon Jun 29 06:54:57 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=910195, encodeId=711291019566, content=请问大概多久分配稿号?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/09/04/700865284ff0a20865522250bbdae373.jpg, createdBy=1d172433504, createdName=vdujun, createdTime=Tue Dec 22 20:57:53 CST 2020, time=2020-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2182576, encodeId=f7b821825e68a, content=请问大家返修都给了多少时间呀?谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=845f5720458, createdName=ms5000000716025452, createdTime=Fri Jan 19 10:02:26 CST 2024, time=2024-01-19, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=807192, encodeId=572a80e192cf, content=两个月了,还在under review. 这么慢的嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=94665282539, createdName=14847382m81(暂无昵称), createdTime=Mon Aug 10 08:45:39 CST 2020, time=2020-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2187185, encodeId=9fd0218e1851a, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:消化病;胃肠道<br>经验分享:第一篇sci,新年最好的礼物,<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'><a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a></a>感谢杂志!编辑和审稿人很认真,从提交到录用共3个月不到,不着急的话推荐投稿! 23.11.15提交 23.11.22under review 15个邀请0接受 24.12.07 under review 21个邀请1接受 24.12.27 under review1个审完 24.1.15 under review22邀请 2个审完 RRC 24.1.15 revise 没有显示大修还是小修,两位审稿人很友好,意见态度也很积极,共不到十条修改意见。 24.1.17 修回 24.1.21 编辑收到,没有送外审,直接给了暂时接受!但提了两条意见。很激动当天修回。 24.2.11 accept 本以为最多两天,苦苦等了半个多月,很煎熬,还好最终大年初二接受了。<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'><a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a></a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/cb0fe5ba5559418e8d524afe6a4ae9c4.jpeg, type=image, width=782, height=306)], authenticateStatus=null, createdAvatar=null, createdBy=b8a09064593, createdName=ms4000001526222582, createdTime=Tue Feb 13 20:21:48 CST 2024, time=2024-02-13, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2149146, encodeId=55f92149146fb, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:肝癌<br>经验分享:中了,很速度,审稿人也很认真,谢谢这篇杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80458221003, createdName=ms5000000357159433, createdTime=Fri Jul 21 14:01:28 CST 2023, time=2023-07-21, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2175408, encodeId=3b7b21e54082a, content=投稿命中率:5.0<br>偏重的研究方向:胃肠道;肝癌<br>经验分享:审稿人也太慢了卧槽, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76045326057, createdName=148bbd99m80暂无昵称, createdTime=Sun Dec 17 10:56:23 CST 2023, time=2023-12-17, status=1, ipAttribution=浙江省)]
    2020-06-29 Godmin

    投稿4天,还是submited to journal. 请问多久可以送审

    4

    展开4条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=1237970, encodeId=f02f123e970fc, content=偏重的研究方向:肝病;肝癌<br>经验分享:开始新的征程,实时分享投稿经历🤡别问我为啥是新征程,因为才被拒稿过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Thu Aug 11 00:51:40 CST 2022, time=2022-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170370, encodeId=4a2a21e037007, content=请问大家同行评审专家都是多久接受邀请啊,我的编辑发了15个邀请 四天啦一个都没接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8a09064593, createdName=ms4000001526222582, createdTime=Wed Nov 22 23:41:33 CST 2023, time=2023-11-22, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=949171, encodeId=c7e99491e1ca, content=我投出去两个半月了,一直在under review ,期待能快一点点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a421634926, createdName=1dd90bdfm89(暂无匿称), createdTime=Thu Mar 18 09:42:08 CST 2021, time=2021-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800183, encodeId=264180018340, content=投稿4天,还是submited to journal. 请问多久可以送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJezw9rLVo7scpm4bIb34WhXb0deaXB8picW5eMAazAJHqyt2iaj4Zw6Uecu7jrAcuWiax5TTGr2reoA/132, createdBy=02e72292772, createdName=Godmin, createdTime=Mon Jun 29 06:54:57 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=910195, encodeId=711291019566, content=请问大概多久分配稿号?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/09/04/700865284ff0a20865522250bbdae373.jpg, createdBy=1d172433504, createdName=vdujun, createdTime=Tue Dec 22 20:57:53 CST 2020, time=2020-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2182576, encodeId=f7b821825e68a, content=请问大家返修都给了多少时间呀?谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=845f5720458, createdName=ms5000000716025452, createdTime=Fri Jan 19 10:02:26 CST 2024, time=2024-01-19, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=807192, encodeId=572a80e192cf, content=两个月了,还在under review. 这么慢的嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=94665282539, createdName=14847382m81(暂无昵称), createdTime=Mon Aug 10 08:45:39 CST 2020, time=2020-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2187185, encodeId=9fd0218e1851a, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:消化病;胃肠道<br>经验分享:第一篇sci,新年最好的礼物,<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'><a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a></a>感谢杂志!编辑和审稿人很认真,从提交到录用共3个月不到,不着急的话推荐投稿! 23.11.15提交 23.11.22under review 15个邀请0接受 24.12.07 under review 21个邀请1接受 24.12.27 under review1个审完 24.1.15 under review22邀请 2个审完 RRC 24.1.15 revise 没有显示大修还是小修,两位审稿人很友好,意见态度也很积极,共不到十条修改意见。 24.1.17 修回 24.1.21 编辑收到,没有送外审,直接给了暂时接受!但提了两条意见。很激动当天修回。 24.2.11 accept 本以为最多两天,苦苦等了半个多月,很煎熬,还好最终大年初二接受了。<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'><a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a></a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/cb0fe5ba5559418e8d524afe6a4ae9c4.jpeg, type=image, width=782, height=306)], authenticateStatus=null, createdAvatar=null, createdBy=b8a09064593, createdName=ms4000001526222582, createdTime=Tue Feb 13 20:21:48 CST 2024, time=2024-02-13, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2149146, encodeId=55f92149146fb, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:肝癌<br>经验分享:中了,很速度,审稿人也很认真,谢谢这篇杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80458221003, createdName=ms5000000357159433, createdTime=Fri Jul 21 14:01:28 CST 2023, time=2023-07-21, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2175408, encodeId=3b7b21e54082a, content=投稿命中率:5.0<br>偏重的研究方向:胃肠道;肝癌<br>经验分享:审稿人也太慢了卧槽, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76045326057, createdName=148bbd99m80暂无昵称, createdTime=Sun Dec 17 10:56:23 CST 2023, time=2023-12-17, status=1, ipAttribution=浙江省)]
    2020-12-22 vdujun

    请问大概多久分配稿号?

    4

    展开4条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=1237970, encodeId=f02f123e970fc, content=偏重的研究方向:肝病;肝癌<br>经验分享:开始新的征程,实时分享投稿经历🤡别问我为啥是新征程,因为才被拒稿过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Thu Aug 11 00:51:40 CST 2022, time=2022-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170370, encodeId=4a2a21e037007, content=请问大家同行评审专家都是多久接受邀请啊,我的编辑发了15个邀请 四天啦一个都没接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8a09064593, createdName=ms4000001526222582, createdTime=Wed Nov 22 23:41:33 CST 2023, time=2023-11-22, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=949171, encodeId=c7e99491e1ca, content=我投出去两个半月了,一直在under review ,期待能快一点点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a421634926, createdName=1dd90bdfm89(暂无匿称), createdTime=Thu Mar 18 09:42:08 CST 2021, time=2021-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800183, encodeId=264180018340, content=投稿4天,还是submited to journal. 请问多久可以送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJezw9rLVo7scpm4bIb34WhXb0deaXB8picW5eMAazAJHqyt2iaj4Zw6Uecu7jrAcuWiax5TTGr2reoA/132, createdBy=02e72292772, createdName=Godmin, createdTime=Mon Jun 29 06:54:57 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=910195, encodeId=711291019566, content=请问大概多久分配稿号?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/09/04/700865284ff0a20865522250bbdae373.jpg, createdBy=1d172433504, createdName=vdujun, createdTime=Tue Dec 22 20:57:53 CST 2020, time=2020-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2182576, encodeId=f7b821825e68a, content=请问大家返修都给了多少时间呀?谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=845f5720458, createdName=ms5000000716025452, createdTime=Fri Jan 19 10:02:26 CST 2024, time=2024-01-19, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=807192, encodeId=572a80e192cf, content=两个月了,还在under review. 这么慢的嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=94665282539, createdName=14847382m81(暂无昵称), createdTime=Mon Aug 10 08:45:39 CST 2020, time=2020-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2187185, encodeId=9fd0218e1851a, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:消化病;胃肠道<br>经验分享:第一篇sci,新年最好的礼物,<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'><a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a></a>感谢杂志!编辑和审稿人很认真,从提交到录用共3个月不到,不着急的话推荐投稿! 23.11.15提交 23.11.22under review 15个邀请0接受 24.12.07 under review 21个邀请1接受 24.12.27 under review1个审完 24.1.15 under review22邀请 2个审完 RRC 24.1.15 revise 没有显示大修还是小修,两位审稿人很友好,意见态度也很积极,共不到十条修改意见。 24.1.17 修回 24.1.21 编辑收到,没有送外审,直接给了暂时接受!但提了两条意见。很激动当天修回。 24.2.11 accept 本以为最多两天,苦苦等了半个多月,很煎熬,还好最终大年初二接受了。<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'><a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a></a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/cb0fe5ba5559418e8d524afe6a4ae9c4.jpeg, type=image, width=782, height=306)], authenticateStatus=null, createdAvatar=null, createdBy=b8a09064593, createdName=ms4000001526222582, createdTime=Tue Feb 13 20:21:48 CST 2024, time=2024-02-13, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2149146, encodeId=55f92149146fb, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:肝癌<br>经验分享:中了,很速度,审稿人也很认真,谢谢这篇杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80458221003, createdName=ms5000000357159433, createdTime=Fri Jul 21 14:01:28 CST 2023, time=2023-07-21, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2175408, encodeId=3b7b21e54082a, content=投稿命中率:5.0<br>偏重的研究方向:胃肠道;肝癌<br>经验分享:审稿人也太慢了卧槽, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76045326057, createdName=148bbd99m80暂无昵称, createdTime=Sun Dec 17 10:56:23 CST 2023, time=2023-12-17, status=1, ipAttribution=浙江省)]
    2024-01-19 ms5000000716025452 来自湖北省

    请问大家返修都给了多少时间呀?谢谢

    3

    展开3条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=1237970, encodeId=f02f123e970fc, content=偏重的研究方向:肝病;肝癌<br>经验分享:开始新的征程,实时分享投稿经历🤡别问我为啥是新征程,因为才被拒稿过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Thu Aug 11 00:51:40 CST 2022, time=2022-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170370, encodeId=4a2a21e037007, content=请问大家同行评审专家都是多久接受邀请啊,我的编辑发了15个邀请 四天啦一个都没接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8a09064593, createdName=ms4000001526222582, createdTime=Wed Nov 22 23:41:33 CST 2023, time=2023-11-22, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=949171, encodeId=c7e99491e1ca, content=我投出去两个半月了,一直在under review ,期待能快一点点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a421634926, createdName=1dd90bdfm89(暂无匿称), createdTime=Thu Mar 18 09:42:08 CST 2021, time=2021-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800183, encodeId=264180018340, content=投稿4天,还是submited to journal. 请问多久可以送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJezw9rLVo7scpm4bIb34WhXb0deaXB8picW5eMAazAJHqyt2iaj4Zw6Uecu7jrAcuWiax5TTGr2reoA/132, createdBy=02e72292772, createdName=Godmin, createdTime=Mon Jun 29 06:54:57 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=910195, encodeId=711291019566, content=请问大概多久分配稿号?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/09/04/700865284ff0a20865522250bbdae373.jpg, createdBy=1d172433504, createdName=vdujun, createdTime=Tue Dec 22 20:57:53 CST 2020, time=2020-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2182576, encodeId=f7b821825e68a, content=请问大家返修都给了多少时间呀?谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=845f5720458, createdName=ms5000000716025452, createdTime=Fri Jan 19 10:02:26 CST 2024, time=2024-01-19, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=807192, encodeId=572a80e192cf, content=两个月了,还在under review. 这么慢的嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=94665282539, createdName=14847382m81(暂无昵称), createdTime=Mon Aug 10 08:45:39 CST 2020, time=2020-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2187185, encodeId=9fd0218e1851a, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:消化病;胃肠道<br>经验分享:第一篇sci,新年最好的礼物,<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'><a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a></a>感谢杂志!编辑和审稿人很认真,从提交到录用共3个月不到,不着急的话推荐投稿! 23.11.15提交 23.11.22under review 15个邀请0接受 24.12.07 under review 21个邀请1接受 24.12.27 under review1个审完 24.1.15 under review22邀请 2个审完 RRC 24.1.15 revise 没有显示大修还是小修,两位审稿人很友好,意见态度也很积极,共不到十条修改意见。 24.1.17 修回 24.1.21 编辑收到,没有送外审,直接给了暂时接受!但提了两条意见。很激动当天修回。 24.2.11 accept 本以为最多两天,苦苦等了半个多月,很煎熬,还好最终大年初二接受了。<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'><a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a></a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/cb0fe5ba5559418e8d524afe6a4ae9c4.jpeg, type=image, width=782, height=306)], authenticateStatus=null, createdAvatar=null, createdBy=b8a09064593, createdName=ms4000001526222582, createdTime=Tue Feb 13 20:21:48 CST 2024, time=2024-02-13, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2149146, encodeId=55f92149146fb, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:肝癌<br>经验分享:中了,很速度,审稿人也很认真,谢谢这篇杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80458221003, createdName=ms5000000357159433, createdTime=Fri Jul 21 14:01:28 CST 2023, time=2023-07-21, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2175408, encodeId=3b7b21e54082a, content=投稿命中率:5.0<br>偏重的研究方向:胃肠道;肝癌<br>经验分享:审稿人也太慢了卧槽, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76045326057, createdName=148bbd99m80暂无昵称, createdTime=Sun Dec 17 10:56:23 CST 2023, time=2023-12-17, status=1, ipAttribution=浙江省)]
    2020-08-10 14847382m81(暂无昵称)

    两个月了,还在under review. 这么慢的嘛

    3

    展开3条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=1237970, encodeId=f02f123e970fc, content=偏重的研究方向:肝病;肝癌<br>经验分享:开始新的征程,实时分享投稿经历🤡别问我为啥是新征程,因为才被拒稿过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Thu Aug 11 00:51:40 CST 2022, time=2022-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170370, encodeId=4a2a21e037007, content=请问大家同行评审专家都是多久接受邀请啊,我的编辑发了15个邀请 四天啦一个都没接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8a09064593, createdName=ms4000001526222582, createdTime=Wed Nov 22 23:41:33 CST 2023, time=2023-11-22, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=949171, encodeId=c7e99491e1ca, content=我投出去两个半月了,一直在under review ,期待能快一点点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a421634926, createdName=1dd90bdfm89(暂无匿称), createdTime=Thu Mar 18 09:42:08 CST 2021, time=2021-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800183, encodeId=264180018340, content=投稿4天,还是submited to journal. 请问多久可以送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJezw9rLVo7scpm4bIb34WhXb0deaXB8picW5eMAazAJHqyt2iaj4Zw6Uecu7jrAcuWiax5TTGr2reoA/132, createdBy=02e72292772, createdName=Godmin, createdTime=Mon Jun 29 06:54:57 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=910195, encodeId=711291019566, content=请问大概多久分配稿号?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/09/04/700865284ff0a20865522250bbdae373.jpg, createdBy=1d172433504, createdName=vdujun, createdTime=Tue Dec 22 20:57:53 CST 2020, time=2020-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2182576, encodeId=f7b821825e68a, content=请问大家返修都给了多少时间呀?谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=845f5720458, createdName=ms5000000716025452, createdTime=Fri Jan 19 10:02:26 CST 2024, time=2024-01-19, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=807192, encodeId=572a80e192cf, content=两个月了,还在under review. 这么慢的嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=94665282539, createdName=14847382m81(暂无昵称), createdTime=Mon Aug 10 08:45:39 CST 2020, time=2020-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2187185, encodeId=9fd0218e1851a, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:消化病;胃肠道<br>经验分享:第一篇sci,新年最好的礼物,<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'><a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a></a>感谢杂志!编辑和审稿人很认真,从提交到录用共3个月不到,不着急的话推荐投稿! 23.11.15提交 23.11.22under review 15个邀请0接受 24.12.07 under review 21个邀请1接受 24.12.27 under review1个审完 24.1.15 under review22邀请 2个审完 RRC 24.1.15 revise 没有显示大修还是小修,两位审稿人很友好,意见态度也很积极,共不到十条修改意见。 24.1.17 修回 24.1.21 编辑收到,没有送外审,直接给了暂时接受!但提了两条意见。很激动当天修回。 24.2.11 accept 本以为最多两天,苦苦等了半个多月,很煎熬,还好最终大年初二接受了。<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'><a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a></a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/cb0fe5ba5559418e8d524afe6a4ae9c4.jpeg, type=image, width=782, height=306)], authenticateStatus=null, createdAvatar=null, createdBy=b8a09064593, createdName=ms4000001526222582, createdTime=Tue Feb 13 20:21:48 CST 2024, time=2024-02-13, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2149146, encodeId=55f92149146fb, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:肝癌<br>经验分享:中了,很速度,审稿人也很认真,谢谢这篇杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80458221003, createdName=ms5000000357159433, createdTime=Fri Jul 21 14:01:28 CST 2023, time=2023-07-21, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2175408, encodeId=3b7b21e54082a, content=投稿命中率:5.0<br>偏重的研究方向:胃肠道;肝癌<br>经验分享:审稿人也太慢了卧槽, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76045326057, createdName=148bbd99m80暂无昵称, createdTime=Sun Dec 17 10:56:23 CST 2023, time=2023-12-17, status=1, ipAttribution=浙江省)]
  9. [GetPortalCommentsPageByObjectIdResponse(id=1237970, encodeId=f02f123e970fc, content=偏重的研究方向:肝病;肝癌<br>经验分享:开始新的征程,实时分享投稿经历🤡别问我为啥是新征程,因为才被拒稿过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Thu Aug 11 00:51:40 CST 2022, time=2022-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170370, encodeId=4a2a21e037007, content=请问大家同行评审专家都是多久接受邀请啊,我的编辑发了15个邀请 四天啦一个都没接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8a09064593, createdName=ms4000001526222582, createdTime=Wed Nov 22 23:41:33 CST 2023, time=2023-11-22, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=949171, encodeId=c7e99491e1ca, content=我投出去两个半月了,一直在under review ,期待能快一点点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a421634926, createdName=1dd90bdfm89(暂无匿称), createdTime=Thu Mar 18 09:42:08 CST 2021, time=2021-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800183, encodeId=264180018340, content=投稿4天,还是submited to journal. 请问多久可以送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJezw9rLVo7scpm4bIb34WhXb0deaXB8picW5eMAazAJHqyt2iaj4Zw6Uecu7jrAcuWiax5TTGr2reoA/132, createdBy=02e72292772, createdName=Godmin, createdTime=Mon Jun 29 06:54:57 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=910195, encodeId=711291019566, content=请问大概多久分配稿号?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/09/04/700865284ff0a20865522250bbdae373.jpg, createdBy=1d172433504, createdName=vdujun, createdTime=Tue Dec 22 20:57:53 CST 2020, time=2020-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2182576, encodeId=f7b821825e68a, content=请问大家返修都给了多少时间呀?谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=845f5720458, createdName=ms5000000716025452, createdTime=Fri Jan 19 10:02:26 CST 2024, time=2024-01-19, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=807192, encodeId=572a80e192cf, content=两个月了,还在under review. 这么慢的嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=94665282539, createdName=14847382m81(暂无昵称), createdTime=Mon Aug 10 08:45:39 CST 2020, time=2020-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2187185, encodeId=9fd0218e1851a, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:消化病;胃肠道<br>经验分享:第一篇sci,新年最好的礼物,<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'><a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a></a>感谢杂志!编辑和审稿人很认真,从提交到录用共3个月不到,不着急的话推荐投稿! 23.11.15提交 23.11.22under review 15个邀请0接受 24.12.07 under review 21个邀请1接受 24.12.27 under review1个审完 24.1.15 under review22邀请 2个审完 RRC 24.1.15 revise 没有显示大修还是小修,两位审稿人很友好,意见态度也很积极,共不到十条修改意见。 24.1.17 修回 24.1.21 编辑收到,没有送外审,直接给了暂时接受!但提了两条意见。很激动当天修回。 24.2.11 accept 本以为最多两天,苦苦等了半个多月,很煎熬,还好最终大年初二接受了。<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'><a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a></a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/cb0fe5ba5559418e8d524afe6a4ae9c4.jpeg, type=image, width=782, height=306)], authenticateStatus=null, createdAvatar=null, createdBy=b8a09064593, createdName=ms4000001526222582, createdTime=Tue Feb 13 20:21:48 CST 2024, time=2024-02-13, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2149146, encodeId=55f92149146fb, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:肝癌<br>经验分享:中了,很速度,审稿人也很认真,谢谢这篇杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80458221003, createdName=ms5000000357159433, createdTime=Fri Jul 21 14:01:28 CST 2023, time=2023-07-21, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2175408, encodeId=3b7b21e54082a, content=投稿命中率:5.0<br>偏重的研究方向:胃肠道;肝癌<br>经验分享:审稿人也太慢了卧槽, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76045326057, createdName=148bbd99m80暂无昵称, createdTime=Sun Dec 17 10:56:23 CST 2023, time=2023-12-17, status=1, ipAttribution=浙江省)]
    2023-07-21 ms5000000357159433 来自云南省

    审稿速度:3.0 | 投稿命中率:50.0
    偏重的研究方向:肝癌
    经验分享:中了,很速度,审稿人也很认真,谢谢这篇杂志

    2

    展开2条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=1237970, encodeId=f02f123e970fc, content=偏重的研究方向:肝病;肝癌<br>经验分享:开始新的征程,实时分享投稿经历🤡别问我为啥是新征程,因为才被拒稿过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Thu Aug 11 00:51:40 CST 2022, time=2022-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170370, encodeId=4a2a21e037007, content=请问大家同行评审专家都是多久接受邀请啊,我的编辑发了15个邀请 四天啦一个都没接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8a09064593, createdName=ms4000001526222582, createdTime=Wed Nov 22 23:41:33 CST 2023, time=2023-11-22, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=949171, encodeId=c7e99491e1ca, content=我投出去两个半月了,一直在under review ,期待能快一点点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a421634926, createdName=1dd90bdfm89(暂无匿称), createdTime=Thu Mar 18 09:42:08 CST 2021, time=2021-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800183, encodeId=264180018340, content=投稿4天,还是submited to journal. 请问多久可以送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJezw9rLVo7scpm4bIb34WhXb0deaXB8picW5eMAazAJHqyt2iaj4Zw6Uecu7jrAcuWiax5TTGr2reoA/132, createdBy=02e72292772, createdName=Godmin, createdTime=Mon Jun 29 06:54:57 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=910195, encodeId=711291019566, content=请问大概多久分配稿号?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/09/04/700865284ff0a20865522250bbdae373.jpg, createdBy=1d172433504, createdName=vdujun, createdTime=Tue Dec 22 20:57:53 CST 2020, time=2020-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2182576, encodeId=f7b821825e68a, content=请问大家返修都给了多少时间呀?谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=845f5720458, createdName=ms5000000716025452, createdTime=Fri Jan 19 10:02:26 CST 2024, time=2024-01-19, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=807192, encodeId=572a80e192cf, content=两个月了,还在under review. 这么慢的嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=94665282539, createdName=14847382m81(暂无昵称), createdTime=Mon Aug 10 08:45:39 CST 2020, time=2020-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2187185, encodeId=9fd0218e1851a, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:消化病;胃肠道<br>经验分享:第一篇sci,新年最好的礼物,<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'><a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a></a>感谢杂志!编辑和审稿人很认真,从提交到录用共3个月不到,不着急的话推荐投稿! 23.11.15提交 23.11.22under review 15个邀请0接受 24.12.07 under review 21个邀请1接受 24.12.27 under review1个审完 24.1.15 under review22邀请 2个审完 RRC 24.1.15 revise 没有显示大修还是小修,两位审稿人很友好,意见态度也很积极,共不到十条修改意见。 24.1.17 修回 24.1.21 编辑收到,没有送外审,直接给了暂时接受!但提了两条意见。很激动当天修回。 24.2.11 accept 本以为最多两天,苦苦等了半个多月,很煎熬,还好最终大年初二接受了。<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'><a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a></a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/cb0fe5ba5559418e8d524afe6a4ae9c4.jpeg, type=image, width=782, height=306)], authenticateStatus=null, createdAvatar=null, createdBy=b8a09064593, createdName=ms4000001526222582, createdTime=Tue Feb 13 20:21:48 CST 2024, time=2024-02-13, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2149146, encodeId=55f92149146fb, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:肝癌<br>经验分享:中了,很速度,审稿人也很认真,谢谢这篇杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80458221003, createdName=ms5000000357159433, createdTime=Fri Jul 21 14:01:28 CST 2023, time=2023-07-21, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2175408, encodeId=3b7b21e54082a, content=投稿命中率:5.0<br>偏重的研究方向:胃肠道;肝癌<br>经验分享:审稿人也太慢了卧槽, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76045326057, createdName=148bbd99m80暂无昵称, createdTime=Sun Dec 17 10:56:23 CST 2023, time=2023-12-17, status=1, ipAttribution=浙江省)]
    2023-12-17 148bbd99m80暂无昵称 来自浙江省

    投稿命中率:5.0
    偏重的研究方向:胃肠道;肝癌
    经验分享:审稿人也太慢了卧槽

    2

    展开2条回复
共152条页码: 1/16页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分